Thu, Jan 29, 2015, 6:28 AM EST - U.S. Markets open in 3 hrs 2 mins


% | $
Quotes you view appear here for quick access.

ImmunoCellular Therapeutics, Ltd. Message Board

  • edwarddpeters edwarddpeters Oct 22, 2012 12:23 PM Flag

    Where is the bottom?

    and when does Phase I results get released? Looking for $1.85 as the low before we get news. Jan. will be the 1 year anniversary of Phase II starting, you would think you would get news about phase I before phase II is fully enrolled.

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • ... and btw, January 2013 will be the 2 year "anniversary of phase II starting", not 1 year.

    • Don't know what you are complaining about. You will find a nice most recent phase I update for ICT-107 on the company website embedded in a worthwhile investor presentation posted Oct.'12., if you go to 'investors' and then 'webcasts&presentations'. If you look for a more 'official' release: ASCO'12 (you find the poster on the same website).

      Most remarkable: The median overall survival is an astounding 38.4 months; two patients (out of 16 = 13%) are still alive with more than 3 years of documented progressive disease; 3 patients (19%) are alive without disease progression for at least 5 years after diagnosis, 6 patients (38%) progression free for 4 years and more. See yourself!

      The proof will be in the randomized phase II trial that is fully recruited and on-going. A planned interim analysis is due Q1/Q2 2013, final results should mature in the second half of 2013.

0.68-0.0200(-2.86%)Jan 28 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Facebook, Inc.
NASDAQWed, Jan 28, 2015 4:00 PM EST
Nokia Corporation
NYSEWed, Jan 28, 2015 4:01 PM EST